Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunosuppressant Adverse Reaction”

3 trials

Showing 3 of 3 results

Post-approval studies (Phase 4)Looking for participantsNCT05242315
What this trial is testing

Extended-Release Tacrolimus Following Liver Transplantation

Who this might be right for
Liver Transplant; ComplicationsRenal InsufficiencyImmunosuppressant Adverse Reaction+2 more
University of Alberta 94
Not applicableEnded earlyNCT04356404
What this trial is testing

Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients

Who this might be right for
Occult Hepatitis BBiological Substance; Adverse EffectImmunosuppression
Chinese University of Hong Kong 68
Not applicableUnknownNCT05707520
What this trial is testing

Long-term Benefit of MPA in Liver Transplantation

Who this might be right for
Liver Transplant RejectionImmunosuppressant Adverse Reaction
Third Affiliated Hospital, Sun Yat-Sen University 500

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation